What Is Ozempic Face? Causes, Who Gets It, Prevention and Treatments That Work
Ozempic face is facial volume loss after rapid weight loss on GLP-1 drugs. What causes it, who is most at risk, how to slow it, and how fillers and biostimulators compare.
"Ozempic face" is a popular, non-medical name for the hollow, older-looking face some people notice after losing a lot of weight quickly on a GLP-1 medicine such as semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound). The short answer: the drug itself is not known to damage facial skin. The change comes mainly from losing facial fat fast, which can leave skin that has less support and looks looser. It is more noticeable after large weight loss and in people over about 40, it can be reduced by losing weight more gradually and protecting skin quality, and it can be treated with fillers or collagen-stimulating injectables once weight is stable.
The short answer
- Ozempic face is not a diagnosis or a listed side effect. It describes facial fat loss after rapid, large weight loss, whatever the cause (Carboni et al., J Drugs Dermatol, 2024).
- GLP-1 drugs cause substantial weight loss. In the STEP 1 trial, adults on semaglutide 2.4 mg lost an average of 14.9% of body weight over 68 weeks versus 2.4% on placebo (Wilding et al., NEJM, 2021). In SURMOUNT-1, tirzepatide 15 mg produced an average loss of 20.9% over 72 weeks (Jastreboff et al., NEJM, 2022).
- The face has separate fat compartments that shrink with age and with weight loss, which is why the cheeks, temples and under-eyes tend to hollow first (Rohrich & Pessa, Plast Reconstr Surg, 2007).
- Treatments that help include hyaluronic acid fillers, poly-L-lactic acid (Sculptra) and calcium hydroxylapatite (Radiesse). Wait until weight has plateaued before treating.
- Never stop or change a prescribed medicine for cosmetic reasons without talking to your prescriber.
Why the face changes after GLP-1 weight loss
Facial fat is not one layer. Anatomy studies show it sits in distinct superficial and deep compartments around the cheeks, temples, eyes and jaw (Cotofana et al., J Dtsch Dermatol Ges, 2019). With normal aging, the deep compartments lose volume and the skin above them loses collagen and elasticity. Rapid weight loss speeds up the volume part of that process in a matter of months.
Plastic surgeons writing about semaglutide note that the facial changes are what you would expect from fast weight loss of any cause, including bariatric surgery: deflated midface, deeper nasolabial folds, hollow temples and a less defined jawline (Humphrey & Lawrence, Facial Plast Surg, 2023). A 2024 review tracked how quickly the term spread online and how few published studies exist on treating it (Mansour et al., J Plast Reconstr Aesthet Surg, 2024). Recent reviews of GLP-1 drugs and skin also point out that data on direct drug effects on skin quality are still limited and mixed (Barone et al., Aesthetic Plast Surg, 2026).
Who is most likely to notice it
| Factor | Why it matters |
|---|---|
| Large total weight loss | More fat lost from every compartment, including the face |
| Fast loss | Skin has less time to adapt |
| Age over ~40 | Less collagen and elastin to "shrink back" |
| Sun damage, smoking | Weaker skin quality before weight loss starts |
| Lean face to begin with | Less fat reserve in the cheeks and temples |
How to reduce your risk
- Ask your prescriber about pace. Dose escalation follows the label for tolerability; slower loss also gives skin more time to adjust.
- Eat enough protein and keep strength training. Losing lean mass along with fat is a known concern with rapid weight loss; protein and resistance exercise help protect it. Ask your doctor or a registered dietitian for a target that fits your health.
- Protect collagen. Daily broad-spectrum SPF 30+ is the best-proven anti-aging step (AAD). See our sunscreen anti-aging guide.
- Use a nightly retinoid if your skin tolerates it. Topical retinoids have the strongest evidence for improving photoaged skin (AAD). Start with our retinol vs retinoid explainer.
- Don't smoke, and keep alcohol low; both accelerate skin aging.
Treatment options once weight is stable
| Treatment | What it does | Typical duration |
|---|---|---|
| Hyaluronic acid filler | Replaces volume right away | About 6–18 months |
| Poly-L-lactic acid (Sculptra) | Stimulates your own collagen gradually | Up to about 2 years |
| Calcium hydroxylapatite (Radiesse) | Volume plus collagen stimulation | About 12 months+ |
These are FDA-regulated devices, and the FDA has a consumer page on what fillers can and can't do and how to avoid unapproved injectables (FDA: Dermal Fillers). A 2026 anatomical review argues that GLP-1-related volume loss often responds best to a combination of collagen stimulation and targeted volume (Frank et al., Dermatol Surg, 2026). For more detail, read our guides to biostimulator fillers, Sculptra vs filler over the long term and how long fillers last. If your main concern is the body rather than the face, see loose skin after GLP-1 weight loss.
Choose a board-certified dermatologist or facial plastic surgeon. Treating while you are still losing weight can mean paying for volume that looks different a few months later.
Frequently asked questions
Does Ozempic directly age your skin?
There is no good evidence that semaglutide directly damages skin. The aged look is mostly from fat loss. Research on direct GLP-1 effects on skin is early and mixed.
Is "Mounjaro face" different from Ozempic face?
No. It is the same pattern of facial volume loss. Tirzepatide tends to cause more average weight loss in trials, so the effect may be more noticeable for some people.
Will Ozempic face go away if I stop the medicine?
If you regain weight, some facial volume may return, but weight regain has its own health effects. Stopping a medicine for cosmetic reasons should be a decision made with your prescriber.
How soon after losing weight can I get fillers?
Many clinicians prefer to wait until weight has been stable for a few months, so the result is planned around your new baseline.
Can skincare alone fix Ozempic face?
Skincare can improve texture, fine lines and pigmentation, but it cannot replace lost fat volume. Retinoids and sunscreen help skin quality; fillers or biostimulators address volume.
Bottom line
Ozempic face is the predictable result of losing facial fat quickly, not a toxic drug effect. Gradual loss, enough protein, strength training, sunscreen and a retinoid help protect your skin, and fillers or collagen stimulators can restore volume once your weight settles. Talk to your doctor before changing a GLP-1 dose, and see a board-certified dermatologist or facial plastic surgeon for treatment.
This article is for educational purposes only and is not medical advice. Talk to your doctor or dermatologist about your situation.
Sources
- Carboni A, et al. Natural Weight Loss or "Ozempic Face": Demystifying a Social Media Phenomenon. J Drugs Dermatol. 2024.
- Humphrey CD, Lawrence AC. Implications of Ozempic and Other Semaglutide Medications for Facial Plastic Surgeons. Facial Plast Surg. 2023.
- Mansour MR, et al. The rise of "Ozempic Face." J Plast Reconstr Aesthet Surg. 2024.
- Barone M, et al. Effects of GLP-1 Receptor Agonists on Skin Quality: A Comprehensive Literature Review. Aesthetic Plast Surg. 2026.
- Frank K, et al. GLP-1-Induced Weight Loss and the Face. Dermatol Surg. 2026.
- Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). NEJM. 2021.
- Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). NEJM. 2022.
- Rohrich RJ, Pessa JE. The fat compartments of the face. Plast Reconstr Surg. 2007.
- Cotofana S, et al. Anatomy of the Facial Fat Compartments. J Dtsch Dermatol Ges. 2019.
- FDA: Dermal Fillers (Soft Tissue Fillers)
- American Academy of Dermatology: Sunscreen FAQs
